Better Therapeutics Financials

Better Therapeutics Stock Summary

Better Therapeutics competes with ABVC Biopharma, Indaptus Therapeutics, Pasithea Therapeutics, Forte Biosciences, and Aerovate Therapeutics. Better Therapeutics, Inc. engages in developing software-based prescription digital therapeutics platform candidates for treating diabetes, heart disease, and other cardiometabolic conditions in the United States. Better Therapeutics, Inc. was founded in 2015 and is headquartered in San Francisco, California. Better Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 44 people.

Better Therapeutics Key Financial Ratios

Better Therapeutics' financial ratios allow both analysts and investors to convert raw data from Better Therapeutics' financial statements into concise, actionable information that can be used to evaluate the performance of Better Therapeutics over time and compare it to other companies across industries.

Better Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Better Therapeutics's current stock value. Our valuation model uses many indicators to compare Better Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Better Therapeutics competition to find correlations between indicators driving Better Therapeutics's intrinsic value. More Info.Better Therapeutics is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Better Therapeutics by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Better Therapeutics' OTC Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

Better Therapeutics Market Pulse

Along with financial statement analysis, the daily predictive indicators of Better Therapeutics help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Better Therapeutics. We use our internally-developed statistical techniques to arrive at the intrinsic value of Better Therapeutics based on widely used predictive technical indicators. In general, we focus on analyzing Better OTC Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Better Therapeutics's daily price indicators and compare them against related drivers.

Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

If you are still planning to invest in Better Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Better Therapeutics' history and understand the potential risks before investing.